Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

TRX vs treadmill: which Warm-Up boosts performance?

NCT ID NCT07215052

Knowledge-focused Sponsor: Tamara Rial-Faigenabum Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at how a suspension training (TRX) warm-up compares to a treadmill walk before a tough exercise test. Researchers want to see if the TRX warm-up leads to similar peak oxygen use and heart-lung responses. The study involves 15 active adults aged 19 to 25 who exercise at least 5 hours per week.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

17 people

The number who actually took part.

Started

Oct 2025

Finished

Jun 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

19 to 25 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Aged 19 to 25 years Engages in ≥5 hours per week of moderate-to-vigorous physical activity (classified as "high activity" based on the International Physical Activity Questionnaire \[ICIQ\]) Able to pass the Physical Activity Readiness Questionnaire (PAR-Q+) screening Exclusion Criteria: Participates in \<5 hours per week of moderate-to-vigorous physical activity Contraindications to maximal cardiopulmonary exercise testing or suspension training Presence of any medical condition that may interfere with safe test participation or data interpretation \-

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Exercise performance are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Exercise performance

Contacts and locations

Locations

  • Monmouth University Graduate Center Room 222

    West Long Branch, New Jersey, 07764, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.